1. A Prediction Model for Tumor Recurrence in Stage II–III Colorectal Cancer Patients: From a Machine Learning Model to Genomic Profiling
   Po-Chuan Chen et al, 2022, Biomedicines CrossRef
2. Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: a prospective, multicenter, open-label, single-arm phase II study
   Tsunekazu Mizushima et al, 2019, BMC Cancer CrossRef